Equity Plans. Each option granted by the Company under the Company’s equity plan was granted (i) in accordance with the terms of the Company’s equity plan and (ii) with an exercise price at least equal to the fair market value of the Ordinary Shares on the date such option would be considered granted under GAAP and applicable law. No option granted under the Company’s equity plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, options prior to, or otherwise knowingly coordinate the grant of options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
Appears in 20 contracts
Sources: Securities Purchase Agreement (Iterum Therapeutics PLC), Underwriting Agreement (Virax Biolabs Group LTD), Underwriting Agreement (Virax Biolabs Group LTD)
Equity Plans. Each share option granted by the Company under the Company’s equity plan was granted (i) in accordance with the terms of the Company’s equity plan and (ii) with an exercise price at least equal to the fair market value of the Ordinary Shares on the date such share option would be considered granted under GAAP and applicable law. No share option granted under the Company’s equity plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, share options prior to, or otherwise knowingly coordinate the grant of share options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
Appears in 13 contracts
Sources: Securities Purchase Agreement (Enlivex Therapeutics Ltd.), Securities Purchase Agreement (Enlivex Therapeutics Ltd.), At the Market Offering Agreement (Canaan Inc.)
Equity Plans. Each stock option granted by the Company under the Company’s equity plan was granted (i) in accordance with the terms of the Company’s equity plan and (ii) with an exercise price at least equal to the fair market value of the Ordinary Shares Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s equity plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
Appears in 9 contracts
Sources: Securities Purchase Agreement (Nixxy, Inc.), Securities Purchase Agreement (Gevo, Inc.), Securities Purchase Agreement (SenesTech, Inc.)
Equity Plans. Each stock option granted by the Company under the Company’s equity plan plans was granted (i) in accordance with the terms of the Company’s equity plan plans and (ii) with an exercise price at least equal to the fair market value of the Ordinary Common Shares on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s equity plan plans has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
Appears in 7 contracts
Sources: Placement Agency Agreement (Niocorp Developments LTD), Placement Agency Agreement (Niocorp Developments LTD), Placement Agency Agreement (Niocorp Developments LTD)
Equity Plans. Each option granted by the Company under the Company’s equity plan plans was granted (i) in accordance with the terms of the Company’s equity plan plans and (ii) with an exercise price at least equal to the fair market value of the Ordinary Shares on the date such option would be considered granted under GAAP and applicable law. No option granted under the Company’s equity plan plans has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, options prior to, or otherwise knowingly coordinate the grant of options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
Appears in 1 contract
Sources: At the Market Offering Agreement (Iterum Therapeutics PLC)